Safety, Tolerability, Pharmacokinetics, and the Effect of Food on TERN-701, an Oral Allosteric BCR-ABL Tyrosine Kinase Inhibitor, in Healthy Participants

被引：0
|
作者：
Anderson, Kacey [1 ]
Holes, Leanne [1 ]
Marmon, Tonya [1 ]
Nichols, Andie [1 ]
Schlegel, Amnon [1 ]
Nelson, Cara [1 ]
Kuriakose, Emil [1 ]
机构：
[1] Terns Pharmaceut, Foster City, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
CML; TERN-701; allosteric BCR-ABL1 tyrosine kinase inhibitor; phase; 1; safety;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-396
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [41] PF-114 Mesylate, a Novel Third Generation ATP-Competitive BCR-ABL Tyrosine Kinase Inhibitor: First Safety and Efficacy Data from a Phase I Study in Patients with CML with Failure of Prior TKI Therapy
    Turkina, Anna G.
    Shukhov, Oleg
    Chelysheva, Ekaterina
    Nemchenko, Irina
    Petrova, Anna
    Bykova, Anastasiya
    Zaritskey, Andrey
    Lomaia, Elza
    Shuvaev, Vasily
    Novikov, Fedor
    Shulgina, Veronika
    Chilov, Ghermes
    BLOOD, 2017, 130
  • [42] Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial
    Liu, Yixian
    Li, Xiaoyu
    Zhang, Mengyu
    Men, Yuchun
    Wang, Ying
    Zhu, Xiaohong
    Zheng, Li
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 515 - 524
  • [43] Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Oral CP-868,596, a Highly Specific Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor in Patients With Advanced Cancers
    Lewis, Nancy L.
    Lewis, Lionel D.
    Eder, Joseph P.
    Reddy, Nandi J.
    Guo, Feng
    Pierce, Kristen J.
    Olszanski, Anthony J.
    Cohen, Roger B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5262 - 5269
  • [44] Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects
    Bello, Carlo L.
    Sherman, Laurie
    Zhou, Jihao
    Verkh, Lev
    Smeraglia, John
    Mount, Janessa
    Klamerus, Karen J.
    ANTI-CANCER DRUGS, 2006, 17 (03) : 353 - 358
  • [45] A Five-Year Follow-up on Safety and Efficacy of Olverembatinib (HQP1351), a Novel Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI), in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) in China
    Jiang, Qian
    Li, Zongru
    Qin, Ya-Zhen
    Zhao, Ting
    Liu, Bingcheng
    Chen, Zi
    Niu, Qian
    Men, Lichuang
    Wang, Hengbang
    Yang, Dajun
    Zhai, Yifan
    Huang, Xiao-Jun
    BLOOD, 2022, 140
  • [46] Safety, Pharmacokinetics, and Biomarker Profile from Phase 1 Clinical Trials of Healthy Volunteers Treated with GDC-0853, a Highly Selective Reversible Oral Bruton's Tyrosine Kinase (BTK) Inhibitor
    Katsumoto, Tamiko
    Winter, Helen
    Kotwal, Shweta
    Murray, Elaine
    Zhao, Rui
    Florero, Marilyn
    Lin, Alyse
    Moein, Anita
    Wang, Rena
    Bremer, Meire
    Kokubu, Serika
    Serone, Adrian
    Morimoto, Alyssa
    Chinn, Leslie
    Herman, Ann
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [47] Safety, tolerability, pharmacokinetics, & pharmacodynamics of LC1 5-0444, a novel dipeptidyl peptidase IV inhibitor, in healthy male subjects: Single ascending dose and food effect study
    Kim, Dong-Kyu
    Lim, Kyoung Soo
    Cho, Joo-Youn
    Yu, Kyung-Sang
    Shin, Sang-Goo
    Kim, Sung-Ho
    Kwon, O. Hwan
    Lee, Sung-Hack
    Lee, Jaeick
    Kim, Jeong-Ae
    Jang, In-Jin
    Yim, Hyeon Joo
    DIABETES, 2008, 57 : A588 - A588
  • [48] A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics and Preliminary Food-Effect Study of TAK-875, GPR40 Agonist, Following Oral Administration of Sequential Ascending Single Doses to Healthy Subjects
    Vakily, Majid
    Wu, Jingtao
    Viswanathan, Prabhakar
    Leifke, Eckhard
    DIABETES, 2010, 59 : A172 - A172
  • [49] First in Human Study of GS-9688, an Oral Toll-like Receptor 8 (TLR8) Agonist, in Healthy Volunteers: Assessment of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect
    Reyes, Maribel
    Lutz, Justin D.
    Lau, Audrey H.
    Gaggar, Anuj
    Grant, Ethan
    Joshi, Adarsh
    Mackman, Richard L.
    Ling, John
    Mathias, Anita
    German, Polina
    Gane, Edward J.
    HEPATOLOGY, 2018, 68 : 233A - 233A
  • [50] Safety, Tolerability, and Pharmacokinetics of the Monoamine Oxidase B Inhibitor, HEC122505, and its Major Metabolite After Single- and Multiple- Ascending Dose, and Food Effect Study in Healthy Chinese Subjects
    Jin, Chuanfei
    Yi, Chao
    Chen, Kangzhi
    Liang, Haiping
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (03) : 331 - 341
12345